Wendy’s Rejects $1.4 Billion Buyout Bid, Adopts Poison Pill
Wendy’s rejected a $1.4 billion buyout offer from an activist investor and adopted a poison pill plan.
Related stories
Critical Metals Completes Acquisition of European Lithium
M impact | MNA | Nov 05, 2026, 02:01 PM UTC
Azimut Expects FSI Authorization Filing for Fintech Bank Transaction
Azimut said FSI is expected to file an authorization request with the Bank of Italy to proceed with a transaction intended to create a new fintech bank. The supplied report says th
L impact | MNA | Nov 05, 2026, 01:57 PM UTC
Qyuns Therapeutics Licenses Antibody Program to Caldera
Qyuns Therapeutics said it is licensing an early-stage antibody program to US biotech Caldera Therapeutics in a deal worth up to $750 million plus an upfront fee.
M impact | MNA | Nov 05, 2026, 01:56 PM UTC
BHAV Acquisition Agreement Values Nemi at $400M Pre-Money
The business combination agreement sets Nemi's pre-money equity value at $400 million, or 40 million shares at $10 per share.
M impact | MNA | Nov 05, 2026, 01:48 PM UTC
Forge Nano Completes HZO Acquisition in All-Stock Deal
Forge Nano completed its acquisition of HZO in an all-stock deal, combining atomic-scale deposition technology with high-volume protective coating capabilities.
M impact | MNA | Nov 05, 2026, 01:35 PM UTC
Wendy’s Rejects Trian’s $1.4 Billion Buyout Offer
Wendy’s board rejected an offer from Nelson Peltz’s Trian Fund Management to buy the fast-food chain for around $1.4 billion. A board committee said the proposal substantially unde
M impact | MNA | Nov 05, 2026, 01:18 PM UTC